Amy E Rothberg1, Laura N McEwen2, Andrew T Kraftson2, Christine E Fowler2, William H Herman2. 1. University of Michigan, Department of Internal Medicine (AER, LNM, ATK, CEF); University of Michigan, Departments of Internal Medicine and Epidemiology (WHH). Electronic address: arothber@umich.edu. 2. University of Michigan, Department of Internal Medicine (AER, LNM, ATK, CEF); University of Michigan, Departments of Internal Medicine and Epidemiology (WHH).
Abstract
BACKGROUND: Current approaches to the management of type 2 diabetes focus on the early initiation of novel pharmacologic therapies and bariatric surgery. OBJECTIVE: The purpose of this study was to revisit the use of intensive, outpatient, behavioral weight management programs for the management of type 2 diabetes. DESIGN: Prospective observational study of 66 patients with type 2 diabetes and BMI ≥ 32 kg/m² who enrolled in a program designed to produce 15% weight reduction over 12 weeks using total meal replacement and low- to moderate-intensity physical activity. RESULTS: Patients were 53 ± 7 years of age (mean ± SD) and 53% were men. After 12 weeks, BMI fell from 40.1 ± 6.6 to 35.1 ± 6.5 kg/m². HbA1c fell from 7.4% ± 1.3% to 6.5% ± 1.2% (57.4 ± 12.3 to 47.7 ± 12.9 mmol/mol) in patients with established diabetes: 76% of patients with established diabetes and 100% of patients with newly diagnosed diabetes achieved HbA1c <7.0% (53.0 mmol/mol). Improvement in HbA1c over 12 weeks was associated with higher baseline HbA1c and greater reduction in BMI. CONCLUSIONS: An intensive, outpatient, behavioral weight management program significantly improved HbA1c in patients with type 2 diabetes over 12 weeks. The use of such programs should be encouraged among obese patients with type 2 diabetes.
BACKGROUND: Current approaches to the management of type 2 diabetes focus on the early initiation of novel pharmacologic therapies and bariatric surgery. OBJECTIVE: The purpose of this study was to revisit the use of intensive, outpatient, behavioral weight management programs for the management of type 2 diabetes. DESIGN: Prospective observational study of 66 patients with type 2 diabetes and BMI ≥ 32 kg/m² who enrolled in a program designed to produce 15% weight reduction over 12 weeks using total meal replacement and low- to moderate-intensity physical activity. RESULTS:Patients were 53 ± 7 years of age (mean ± SD) and 53% were men. After 12 weeks, BMI fell from 40.1 ± 6.6 to 35.1 ± 6.5 kg/m². HbA1c fell from 7.4% ± 1.3% to 6.5% ± 1.2% (57.4 ± 12.3 to 47.7 ± 12.9 mmol/mol) in patients with established diabetes: 76% of patients with established diabetes and 100% of patients with newly diagnosed diabetes achieved HbA1c <7.0% (53.0 mmol/mol). Improvement in HbA1c over 12 weeks was associated with higher baseline HbA1c and greater reduction in BMI. CONCLUSIONS: An intensive, outpatient, behavioral weight management program significantly improved HbA1c in patients with type 2 diabetes over 12 weeks. The use of such programs should be encouraged among obesepatients with type 2 diabetes.
Authors: Stacy A Brethauer; Ali Aminian; Héctor Romero-Talamás; Esam Batayyah; Jennifer Mackey; Laurence Kennedy; Sangeeta R Kashyap; John P Kirwan; Tomasz Rogula; Matthew Kroh; Bipan Chand; Philip R Schauer Journal: Ann Surg Date: 2013-10 Impact factor: 12.969
Authors: Philip R Schauer; Sangeeta R Kashyap; Kathy Wolski; Stacy A Brethauer; John P Kirwan; Claire E Pothier; Susan Thomas; Beth Abood; Steven E Nissen; Deepak L Bhatt Journal: N Engl J Med Date: 2012-03-26 Impact factor: 91.245
Authors: H Kahleova; A Mari; V Nofrate; M Matoulek; L Kazdova; M Hill; T Pelikanova Journal: J Diabetes Complications Date: 2012-06-04 Impact factor: 2.852
Authors: D M Nathan; J B Buse; M B Davidson; E Ferrannini; R R Holman; R Sherwin; B Zinman Journal: Diabetologia Date: 2008-10-22 Impact factor: 10.122
Authors: W J Pories; M S Swanson; K G MacDonald; S B Long; P G Morris; B M Brown; H A Barakat; R A deRamon; G Israel; J M Dolezal Journal: Ann Surg Date: 1995-09 Impact factor: 12.969
Authors: Ricardo V Cohen; Jose C Pinheiro; Carlos A Schiavon; João E Salles; Bernardo L Wajchenberg; David E Cummings Journal: Diabetes Care Date: 2012-07 Impact factor: 19.112
Authors: Amy E Rothberg; Laura N McEwen; Tom Fraser; Charles F Burant; William H Herman Journal: Obesity (Silver Spring) Date: 2013-10-17 Impact factor: 5.002
Authors: Corey J Lager; Nazanene H Esfandiari; Angela R Subauste; Andrew T Kraftson; Morton B Brown; Ruth B Cassidy; Darlene Bellers; Amy L Lockwood; Oliver A Varban; Elif A Oral Journal: Obes Surg Date: 2017-07 Impact factor: 4.129
Authors: M Caprio; M Infante; E Moriconi; A Armani; A Fabbri; G Mantovani; S Mariani; C Lubrano; E Poggiogalle; S Migliaccio; L M Donini; S Basciani; A Cignarelli; E Conte; G Ceccarini; F Bogazzi; L Cimino; R A Condorelli; S La Vignera; A E Calogero; A Gambineri; L Vignozzi; F Prodam; G Aimaretti; G Linsalata; S Buralli; F Monzani; A Aversa; R Vettor; F Santini; P Vitti; L Gnessi; U Pagotto; F Giorgino; A Colao; A Lenzi Journal: J Endocrinol Invest Date: 2019-05-20 Impact factor: 4.256
Authors: Kristen M Ward; Larisa Yeoman; Cora McHugh; A Zarina Kraal; Stephanie A Flowers; Amy E Rothberg; Alla Karnovsky; Arun K Das; Vicki L Ellingrod; Kathleen A Stringer Journal: Pharmacotherapy Date: 2018-06 Impact factor: 4.705
Authors: Sandro La Vignera; Rossella Cannarella; Fabio Galvano; Agata Grillo; Antonio Aversa; Laura Cimino; Cristina M Magagnini; Laura M Mongioì; Rosita A Condorelli; Aldo E Calogero Journal: Endocrine Date: 2020-10-15 Impact factor: 3.633
Authors: Amy E Rothberg; Laura N McEwen; Andrew T Kraftson; Nevin Ajluni; Christine E Fowler; Catherine K Nay; Nicole M Miller; Charles F Burant; William H Herman Journal: BMJ Open Diabetes Res Care Date: 2017-02-20
Authors: Daniel König; Denise Zdzieblik; Peter Deibert; Aloys Berg; Albert Gollhofer; Martin Büchert Journal: Nutrients Date: 2015-12-01 Impact factor: 5.717